[ON THE THERAPEUTIC USE OF HORMONAL OVULATION BLOCK].
D003267:Contraception; D004412:Dysmenorrhea; D004715:Endometriosis; D004997:Ethinyl Estradiol; D005260:Female; D006801:Humans; D007246:Infertility; D007247:Infertility, Female; D008599:Menstruation Disturbances; D008796:Metrorrhagia; D009640:Norethindrone; D010060:Ovulation; D000292:Pelvic Inflammatory Disease; D006473:Postpartum Hemorrhage; D049590:Postpartum Period; D014116:Toxicology; D014592:Uterine Hemorrhage
D004997:Ethinyl Estradiol; D009640:Norethindrone
ADNEXITIS; CONTRACEPTION; DYSMENORRHEA; ENDOMETRIOSIS; ETHINYL ESTRADIOL; HEMORRHAGE, POSTPARTUM; MENSTRUATION DISORDERS; METRORRHAGIA; NORETHINDRONE; STERILITY, FEMALE; TOXICOLOGIC REPORT; UTERINE HEMORRHAGE
ZUR THERAPEUTISCHEN VERWENDBARKEIT DER HORMONELLEN OVULATIONSBLOCKADE.